Education
About Us
Working with TipRanks
Follow Us
Aurora Cannabis (ACB)
NASDAQ:ACB
ACB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.42 - $9.35
Previous Close$4.5
Volume634.82K
Average Volume (3M)1.80M
Market Cap
$244.97M
Enterprise Value$295.58M
Total Cash (Recent Filing)C$46.77M
Total Debt (Recent Filing)C$347.56M
Price to Earnings (P/E)29.0
Beta1.06
Next Earnings
Jun 19, 2025EPS Estimate
0.1Last Dividend Ex-Date
Aug 23, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)0.16
Shares Outstanding54,884,052
10 Day Avg. Volume1,083,859
30 Day Avg. Volume1,799,927
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.09
Price to Cash Flow (P/CF)3.00
P/FCF Ratio3.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.10Price Target Upside55.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Aurora Cannabis News
PremiumStock Analysis & Ideas
TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
PremiumCompany Announcements
Aurora Cannabis Unveils Mildew-Resistant Cannabis Breakthrough
PremiumCompany Announcements
Aurora Cannabis Enhances Access to Medical Cannabis in Australia
PremiumCompany Announcements
Aurora Cannabis Secures Strategic $27 Million Supply Agreement with SNDL
---
Bulls Say, Bears Say
Bulls Say
Market PositionACB generates 80% of its cannabis sales from medical, a market with higher gross margin, greater price stability, and more predictable cash flows.
Regulatory OpportunitiesA federal re-scheduling in the U.S. should provide benefits including increased research, lower stigma, improve access to capital, and unlock the world's biggest addressable cannabis market.
Strategic ShiftACB has turned over a proverbial new leaf following the reset in the cannabis industry, now with a focus on responsible growth.
Bears Say
Industry RisksThere are lingering risks in the emerging cannabis industry including rampant illicit markets, limited insurance coverage, and unpredictable path to further de-regulation.
Operational ChallengesThere are administration delays in settlement payments.
---
Ownership Overview
0.40% Insiders
0.09% Mutual Funds
0.85% Other Institutional Investors
95.05% Public Companies and
Individual Investors
ACB FAQ
What was Aurora Cannabis’s price range in the past 12 months?
Aurora Cannabis lowest stock price was $3.42 and its highest was $9.35 in the past 12 months.
What is Aurora Cannabis’s market cap?
Aurora Cannabis’s market cap is $244.97M.
When is Aurora Cannabis’s upcoming earnings report date?
Aurora Cannabis’s upcoming earnings report date is Jun 19, 2025 which is in 85 days.
How were Aurora Cannabis’s earnings last quarter?
Aurora Cannabis released its earnings results on Feb 05, 2025. The company reported $0.398 earnings per share for the quarter, beating the consensus estimate of $0.003 by $0.395.
Is Aurora Cannabis overvalued?
According to Wall Street analysts Aurora Cannabis’s price is currently Undervalued.
Does Aurora Cannabis pay dividends?
Aurora Cannabis pays a Notavailable dividend of $8.281 which represents an annual dividend yield of N/A. See more information on Aurora Cannabis dividends here
What is Aurora Cannabis’s EPS estimate?
Aurora Cannabis’s EPS estimate is 0.1.
How many shares outstanding does Aurora Cannabis have?
Aurora Cannabis has 54,884,052 shares outstanding.
What happened to Aurora Cannabis’s price movement after its last earnings report?
Aurora Cannabis reported an EPS of $0.398 in its last earnings report, beating expectations of $0.003. Following the earnings report the stock price went up 45.924%.
Which hedge fund is a major shareholder of Aurora Cannabis?
Currently, no hedge funds are holding shares in ACB
---
Aurora Cannabis Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.10 (55.36% Upside)
$7.10 (55.36% Upside)
Blogger Sentiment
Bullish
ACB Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $87.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.96%
12-Months-Change
Fundamentals
Return on Equity
4.78%
Trailing 12-Months
Asset Growth
-2.78%
Trailing 12-Months
Company Description
Aurora Cannabis
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
---
ACB Company Deck
---
ACB Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, particularly in international market growth and record-breaking profitability. Despite a decline in Canadian recreational revenue and increased SG&A expenses, the company's robust financial position and operational efficiency improvements suggest a positive outlook.Read More>---
ACB Stock 12 Month Forecast
Average Price Target
$7.10
▲(55.36% Upside)
Technical Analysis
Best Analysts Covering ACB
1 Year
1 Year Success Rate
8/19 ratings generated profit
1 Year Average Return
-4.25%
reiterated a buy rating 2 months ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -4.25% per trade.
---